Clinical Trials · NCT07225829
A Trial to Investigate the Safety and Efficacy of Intra-articular 4P004 Injection in Subjects With Knee Synovitis and Osteoarthritis
- Phase
- Phase 2
- Recruitment status
- Active Not Recruiting
- Sponsor
- 4Moving Biotech
- Enrollment
- 129
- Start date
- Jun 2025
- Locations
- 22 sites, 6 countries
- Primary endpoint
- Change from Baseline at Week 4 in the weekly average of Target Knee (TK) daily pain intensity using the WOMAC (Western Ontario and McMaster Universities Arthritis Index) Pain subscore